SmartPilots’ objective is to improve regional policies in support of Shared Pilot Facilities to increase their impact within the deployement on the Key Enabling technology (KET) Industrial Biotech and the bioeconomy.

The bioeconomy adresses societal challenges such as climate change, sustainable economic growth and energy independence. The bioeconomy enables the sustainable production of chemicals, pharmaceutical products, materials, food, feed and energy from renewable raw materials. Shared pilot facilities are open access test sites that bring bioeconomy innovations from the laboratory into industrial practice. They are open to all companies and research institutes, and can thus be seen as shared investments in innovation equipment. They have proven to be successful in helping innovators, especially SMEs, to bridge the so called Valley of Death, i.e. the innovation phase between between laboratory and successful market introduction that comes with a high technological and financial risk. Typically, initial funding from governments is available to build a Shared Pilot Facility, but it is a challenge to safeguard their long-term existence, especially since bioeconomy is relatively new and dedicated policies are currently lacking in many regions.

In SmartPilots, regional policies will be improved to provide support in a cost-effective and impact oriented manner. This will be done by:

  • optimizing direct support for shared pilot facilities,
  • optimizing indirect support i.e. direct support for users of shared pilot facilities,
  • by facilitating interregional cooperation regarding Shared Pilot Facilities.

The Shared Pilot Facilities and regions involved are Bio Base Europe Pilot Plant and the Department of Economy, Science and Innovation from Flanders (Belgium), Centre for Process Innovation from Tees Valley (UK), VTT Technical Research Centre Ltd from Helsinki (Finland), Bioprocess Pilot Facility and Provincie Zuid Holland (the Netherlands), Innovhub SSI from Lombardy (Italy) and ARD (France) and Fraunhofer CBP (Germany) as Case Studies.

Contact Details:

Lieve Hoflack
Rodenhuizekaai 1, Gent, Belgium,B – 9042

This project has received funding from the Bio Based Industries Joint Undertaking under the European Union’s 'Horizon 2020 Research and Innovation Programme', under Grant Agreement No 730052